---
layout: minimal-medicine
title: Phytonadione (Vitamin K)
---

# Phytonadione (Vitamin K)
### Generic Name
Phytonadione (Vitamin K)

### Usage

Phytonadione, also known as Vitamin K, is primarily used to treat and prevent bleeding disorders related to vitamin K deficiency.  Its main application is in addressing hypoprothrombinemia, a condition where the blood doesn't clot properly due to low levels of prothrombin, a vital clotting factor.  This deficiency can arise from various causes, including:

* **Treatment with anticoagulants:** Medications like warfarin (Coumadin) interfere with vitamin K's role in blood clotting, leading to hypoprothrombinemia. Phytonadione helps reverse this effect.
* **Antibiotic therapy:**  Certain antibiotics can disrupt the gut bacteria responsible for producing vitamin K, resulting in deficiency.
* **Limited absorption or synthesis of vitamin K:** Conditions affecting the intestines (malabsorption syndromes) or liver (where vitamin K is processed) can impair the body's ability to obtain and utilize vitamin K.

Phytonadione is also crucial in preventing and treating bleeding in newborns, particularly those at risk of vitamin K deficiency bleeding (VKDB).  This is a common reason for prophylactic administration of vitamin K to infants shortly after birth.

### Dosage

Dosage varies greatly depending on the reason for administration, the patient's age, and the route of administration.  Always follow a healthcare professional's specific instructions.  The information below is for general knowledge and should not be considered medical advice.

**Adults:**

Treatment of acquired hypoprothrombinemia typically involves doses ranging from 2.5 mg to 25 mg, occasionally up to 50 mg, administered subcutaneously (SubQ), intramuscularly (IM), or intravenously (IV).  For reversing the effects of anticoagulant medication, similar dosages are used, often repeated after 6-8 hours if necessary. The oral route is generally preferred for less severe cases, unless absorption is impaired.  IV administration should be slow to avoid serious adverse reactions.

**Children:**

For newborn hemorrhage, a typical dose is 1 mg IM or SubQ; higher doses may be needed if the mother received anticoagulant therapy. Prophylactic treatment in newborns usually involves 0.5-1 mg IM or SubQ shortly after birth, with dosage adjustments based on the infant's prematurity and weight. Oral administration may be considered in specific cases.  For treating acquired hypoprothrombinemia in children, oral doses of 2.5-10 mg per day are common, with higher doses possibly required and administered via IM, SubQ, or IV.


**Important Note:**  The information provided is a summary. Specific dosages must be determined by a healthcare professional based on individual patient needs and circumstances.


### Side Effects

Common side effects are rare but can include injection site reactions (pain, swelling, redness), and rarely, allergic reactions.

Less common, but potentially serious, side effects include:

* Anaphylaxis (severe allergic reaction) â€“ particularly with rapid IV administration.  This is a life-threatening emergency.
* Hypotension (low blood pressure)
* Hyperbilirubinemia (high bilirubin levels in newborns)
* Skin reactions (rashes, itching)


If you experience any side effects, particularly severe ones, seek immediate medical attention.

### How it Works

Phytonadione acts as a cofactor, assisting an enzyme in the liver that converts inactive clotting factors into their active forms. These factors (II, VII, IX, and X) are essential components of the blood coagulation cascade, the process that stops bleeding. By enabling the activation of these factors, phytonadione helps restore normal blood clotting ability.


### Precautions

* **Allergy:**  Individuals with known hypersensitivity to phytonadione or any of its components should not use it.
* **Liver or kidney disease:** Use with caution in patients with pre-existing liver or kidney problems.
* **Premature infants:**  Special considerations are necessary when administering phytonadione to premature infants due to potential risks of hyperbilirubinemia.
* **Drug Interactions:**  Phytonadione's effects can be altered by certain medications, therefore consult a healthcare professional about all medications taken.
* **Pregnancy and breastfeeding:** Phytonadione is categorized as pregnancy category C.  The benefits must outweigh the potential risks to the fetus. While present in small quantities in breast milk,  the American Academy of Pediatrics recommends a separate dose for all newborns.

### FAQs

**Q: How should I store Phytonadione?**

A:  Storage instructions vary depending on the formulation. Follow the specific instructions on the product label. Generally, protection from light and extreme temperatures is recommended.

**Q: Can I take Phytonadione without a doctor's prescription?**

A:  No. Phytonadione should only be used under the supervision of a healthcare professional who can determine the appropriate dosage and monitor for any adverse effects. Self-medicating can be dangerous.

**Q: What should I do if I miss a dose?**

A: Contact your doctor or pharmacist for guidance; do not double the dose.

**Q: Is Phytonadione safe for long-term use?**

A: Long-term use is typically not necessary unless there is an ongoing deficiency or a chronic need for anticoagulant reversal.  Consult a healthcare professional to determine the appropriate duration of treatment.

**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting any medication, including phytonadione, to ensure its appropriateness and safe use.
